Eurofins Scientific S.E., founded in 1987 and headquartered in Luxembourg, is a global leader in bioanalytical testing and analysis, dedicated to providing high-quality laboratory services to clients across various industries. The company specializes in food, environment, pharmaceutical, and clinical diagnostics, offering a range of services including testing, research, and product development.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| ERFFP 0.88% 2031-05-19 EUREurofins Scientific S.E. | Luxembourg | 2031-05-19 | 0.875 | 3.49 |
| ERFFP 3.25% Undated EUREurofins Scientific S.E. | Luxembourg | Undated | 3.250 | 6.48 |
| ERFFP 3.75% 2026-07-17 EUREurofins Scientific S.E. | Luxembourg | 2026-07-17 | 3.750 | 2.81 |
| ERFFP 3.88% 2033-02-05 EUREurofins Scientific S.E. | Luxembourg | 2033-02-05 | 3.875 | 3.86 |
| ERFFP 4.00% 2029-07-06 EUREurofins Scientific S.E. | Luxembourg | 2029-07-06 | 4.000 | 3.09 |
| ERFFP 4.75% 2030-09-06 EUREurofins Scientific S.E. | Luxembourg | 2030-09-06 | 4.750 | 3.36 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Eurofins began issuing bonds in 2017, having established a series of significant bond offerings to support its rapid growth and acquisitions. Notably, a €300 million issuance in 2020 was used to finance a strategic acquisition that expanded its capabilities in the clinical diagnostics sector. Current yields on Eurofins' bonds are competitive within the industry, reflecting the company's strong market position and solid financial health. Recent interest in their bonds has been driven by ongoing expansion efforts and the resilience of their business model amid market fluctuations.